case stringlengths 641 3.97k | reasoning stringlengths 324 937 | answer stringlengths 1.44k 6k | category stringclasses 4
values |
|---|---|---|---|
Mr. Elias Vance is an 82-year-old African American male presenting to the ED with worsening shortness of breath. He has a known history of Stage III Chronic Obstructive Pulmonary Disease (GOLD classification) complicated by frequent exacerbations, poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), ischemic heart ... | Severe COPD exacerbation with pneumonia, high risk mortality.
Diabetes impairs immune function, worsening infection outcome.
CKD increases susceptibility to infection and complications.
Prior MI increases cardiovascular risk during acute illness.
Influenza A increases pneumonia severity and mortality.
Elevated BNP sugg... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case with multiple interacting comorbidities significantly impacting his prognosis. His acute illness – a severe COPD exacerbation complicated by influenza A pneumonia – is superimposed on a background of substantial physiological reserve depleti... | prognostic |
A 9-year-old female of mixed African-American and Caucasian descent presents with a known diagnosis of severe mitral valve stenosis (MVS) secondary to rheumatic heart disease, diagnosed 2 years prior. She initially presented with mild dyspnea on exertion, but now reports progressive shortness of breath (NYHA Class III)... | Severe MVS: significantly limits cardiac output, worsening symptoms.
Recurrent Afib: increases stroke risk, heart failure progression.
Elevated PASP: indicates pulmonary hypertension, poor prognosis.
Rheumatic etiology: potential for valve recurrence/progression.
Family history SCD: suggests genetic predisposition to a... | # Prognostic Assessment for Severe Mitral Valve Stenosis
This 9-year-old female with severe rheumatic mitral valve stenosis presents a complex prognostic challenge due to multiple interacting risk factors. Her prognosis needs to be considered across short, medium, and long-term horizons.
**Short-Term Prognosis (Days ... | prognostic |
A 72-year-old female, Mrs. Eleanor Vance, presents with known cirrhosis (Child-Pugh B, MELD score 18) secondary to non-alcoholic steatohepatitis (NASH) diagnosed 5 years ago. She was initially well-compensated but has experienced increasing ascites over the past 6 months, requiring weekly paracentesis. She also has a h... | Cirrhosis severity: Child-Pugh B, MELD 18 indicates moderate risk.
HCC stage: Early stage (BCLC 0/A) offers treatment options.
Diabetes impacts liver disease progression and treatment tolerance.
Renal impairment limits treatment options, increases complications.
Ascites frequency: Weekly paracentesis suggests worsening... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance faces a moderate risk of short-term complications. The recent SBP episode, even with treatment, increases the risk of re-infection and hepatic encephalopathy. Her ascites management is challenging, and further episodes ... | prognostic |
Mr. Elias Vargas is a 72-year-old Hispanic male presenting for follow-up of Stage III (T3N1M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He completed 6 cycles of cisplatin/pemetrexed chemotherapy 3 months ago, achieving stable disease per recent CT scan. He has a significant ... | Stage III NSCLC indicates aggressive disease potential.
Smoking history significantly elevates recurrence risk.
Diabetes impairs immune function, hindering response.
CKD impacts chemotherapy tolerance and recovery.
PAD limits exercise capacity, affecting quality of life.
Stable disease post-chemo is a positive indicato... | # Prognostic Assessment for Mr. Elias Vargas
**Short-Term Prognosis (Days to Weeks):**
Mr. Vargas is currently stable, but faces a moderate risk of symptom exacerbation (fatigue, dyspnea) due to underlying lung cancer and comorbidities. Acute complications related to CKD (e.g., hyperkalemia) or PAD (e.g., non-healing ... | prognostic |
A 28-year-old female presents with a 6-month history of progressive nasal obstruction, epistaxis, and left facial swelling. Initial evaluation revealed a locally advanced, high-grade squamous cell carcinoma (SCC) of the left maxillary sinus (T4N2M0, Stage III). Biopsy confirmed poorly differentiated SCC, positive for p... | Advanced stage SCC significantly worsens prognosis.
Poor differentiation indicates aggressive tumor biology.
Smoking history increases recurrence and mortality risk.
Crohn’s/Infliximab: immunosuppression, healing compromise.
Orbital involvement complicates surgical resection.
P16 positivity suggests potential for poore... | # Prognostic Assessment: Maxillary Sinus SCC
This 28-year-old female with Stage III maxillary sinus SCC presents a complex prognostic scenario due to multiple interacting risk factors and comorbidities.
**Short-Term Prognosis (Days to Weeks):**
The immediate post-treatment period (planned intensity-modulated radiati... | prognostic |
A 48-year-old African American female with a 12-year history of Type 2 Diabetes Mellitus (HbA1c consistently 8.5-9.5%) and poorly controlled hypertension (average BP 150/90 mmHg despite multiple medications) presents with rapidly progressive edema and fatigue over the past 3 months. She was diagnosed with IgA nephropat... | IgA nephropathy progressing to rapidly progressive glomerulonephritis.
Diabetes and hypertension accelerate kidney disease progression.
Low eGFR indicates advanced chronic kidney disease stage 4.
High UPCR signifies significant proteinuria, worsening prognosis.
Anemia contributes to fatigue and reduced functional statu... | # Prognostic Assessment for IgA Nephropathy with Rapid Progression
This 48-year-old African American female with IgA nephropathy, complicated by diabetic nephropathy, hypertensive nephrosclerosis, and significant comorbidities, faces a guarded prognosis. The recent biopsy demonstrating crescentic glomerulonephritis in... | prognostic |
Eight-year-old female, Maya, presents with a confirmed diagnosis of Severe Obsessive-Compulsive Disorder (OCD) with primarily contamination and symmetry/ordering obsessions. Diagnosis established 18 months ago based on Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score consistently >30. Maya experiences significant f... | Severe OCD indicates poorer initial treatment response.
Co-morbid anxiety worsens overall functional impairment.
Family history suggests genetic vulnerability.
Partial SSRI response predicts slower improvement.
Cognitive inflexibility hinders exposure therapy efficacy.
Recent relocation adds significant psychosocial st... | # Prognostic Assessment for Maya – Severe OCD
**Short-Term Prognosis (Days to Weeks):**
Maya’s short-term prognosis is guarded. While continued Fluoxetine treatment is essential, the partial response suggests limited immediate improvement. Expect continued functional impairment, particularly regarding school attendanc... | prognostic |
A 28-year-old female presents with a 3-year history of Crohn’s disease, initially diagnosed with ileal involvement (L1). She has experienced frequent flares despite multiple trials of immunomodulators (azathioprine, methotrexate) and currently requires intermittent intravenous steroids for symptom control. Recent imagi... | Crohn’s disease: stricturing/fistulizing phenotype, severe activity.
Prior biologic failure indicates potential treatment refractoriness.
DVT history complicates biologic therapy selection.
Smoking significantly worsens disease course and complications.
Malnutrition impacts healing and increases infection risk.
Anxiety... | # Prognostic Assessment for Crohn’s Disease
This 28-year-old female with Crohn’s disease presents a complex case with multiple high-risk factors impacting her prognosis. Her disease is progressing despite conventional therapies, exhibiting both stricturing and fistulizing behavior, indicating a more aggressive phenoty... | prognostic |
Mr. David Miller is a 52-year-old male with a history of well-controlled hypertension and hyperlipidemia, presenting with newly diagnosed Stage IV (T3N2M1) non-small cell lung cancer (NSCLC) – adenocarcinoma histology. Initial imaging (CT chest/abdomen/pelvis, brain MRI) reveals a 7cm right upper lobe mass with mediast... | Stage IV NSCLC inherently carries poor prognosis.
EGFR mutation predicts response to targeted therapy.
Brain metastases indicate aggressive disease course.
ECOG 1 suggests relatively good functional status.
Renal impairment limits treatment options/tolerability.
Liver involvement (ALP) suggests wider disease burden.
Pr... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents with a complex case of Stage IV EGFR-mutated NSCLC, requiring a nuanced prognostic assessment considering multiple interacting factors.
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller’s short-term prognosis is largely dependent on his initial respo... | prognostic |
A 48-year-old Vietnamese-American female with a history of intravenous drug use (IVDU) and poorly controlled HIV (CD4 count 180 cells/µL, viral load 850,000 copies/mL) presents with a 3-week history of worsening cough, fever, night sweats, and unintentional weight loss (15 lbs). She was diagnosed with disseminated *Pne... | Severe immunosuppression due to advanced HIV and HCV.
PCP indicates profound immune compromise, high mortality risk.
Hepatitis C cirrhosis complicates treatment and prognosis.
IVDU history increases risk of further infections/complications.
Poor ART adherence hinders immune reconstitution potential.
Low CD4 count predi... | # Prognostic Assessment for Disseminated *Pneumocystis jirovecii* Pneumonia (PCP) in a Complex Patient
This 48-year-old female with disseminated PCP, advanced HIV, Hepatitis C cirrhosis, and significant psychosocial challenges presents a highly complex prognostic scenario. Her prognosis is guarded, with significant mo... | prognostic |
An 8-year-old male of Navajo ethnicity presents with confirmed disseminated Mycobacterium tuberculosis (TB) infection, complicated by HIV co-infection (CD4 count 250 cells/µL). He was diagnosed 3 weeks ago after presenting with fever, weight loss (10% of baseline), night sweats, and a persistent cough. Chest X-ray reve... | Disseminated TB with HIV significantly worsens prognosis.
MCID increases susceptibility to severe infections.
Low CD4 count indicates advanced HIV disease.
Nutritional compromise impairs immune response.
Inconsistent adherence threatens treatment efficacy.
Neutropenia increases secondary infection risk.
Navajo ethnicit... | # Prognostic Assessment: Disseminated TB/HIV/MCID
This 8-year-old Navajo male with disseminated TB, HIV co-infection, and mild combined immunodeficiency (MCID) presents a complex and concerning case with a guarded prognosis. Accurate prognostic assessment requires considering the interplay of these factors.
**Short-T... | prognostic |
Mr. Elias Vance is a 68-year-old African American male with a history of well-controlled hypertension and type 2 diabetes mellitus (HbA1c 7.2%) presenting with newly diagnosed Stage IV Non-Small Cell Lung Cancer (NSCLC) – adenocarcinoma histology. He was a heavy smoker (60 pack-years) who quit 5 years ago. Initial imag... | Stage IV NSCLC indicates poor overall prognosis.
EGFR mutation suggests potential targeted therapy response.
Weight loss signifies advanced disease and poor reserve.
ECOG 2 indicates moderate functional impairment.
Renal impairment complicates treatment options.
Low albumin reflects malnutrition and disease burden.
Soc... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of Stage IV NSCLC with multiple factors influencing his prognosis. His adenocarcinoma histology with an EGFR exon 19 deletion is a positive prognostic indicator, suggesting potential responsiveness to EGFR tyrosine kinase inhibitors (TKIs). ... | prognostic |
A 16-year-old male, Jamal, presents with a confirmed diagnosis of Standard Risk B-cell Acute Lymphoblastic Leukemia (B-ALL), achieved complete remission after induction chemotherapy (MRC UKALL XII protocol). However, his initial presentation included a very high white blood cell count (300 x 10^9/L) and evidence of CNS... | B-ALL remission status: initially favorable, now concerning MRD.
High initial WBC count: indicates aggressive disease biology.
CNS involvement: increases relapse risk significantly.
TP53 mutation: strong predictor of treatment failure.
Asthma/Obesity: potential for treatment-related complications.
Psychosocial stress: ... | # Prognostic Assessment for Jamal - B-ALL
## Summary
Jamal, a 16-year-old male with B-ALL initially classified as standard risk, presents a complex prognostic scenario due to multiple adverse features despite achieving initial remission. The presence of a *TP53* germline mutation, CNS involvement at diagnosis, high in... | prognostic |
A 16-year-old female, Sarah, presents with a confirmed diagnosis of Multiple Sclerosis (MS), relapsing-remitting type, established 2 years ago. Initial presentation involved optic neuritis and sensory disturbances in her left leg. Current MRI shows 12 T2 lesions, 3 with gadolinium enhancement. EDSS (Expanded Disability... | Relapsing-remitting MS, early disease course, moderate severity.
High relapse rate suggests aggressive disease phenotype.
Family history increases MS risk and potential severity.
MRI lesion load indicates substantial inflammatory activity.
EDSS 4.0 signifies established neurological impairment.
Vitamin D deficiency lin... | # Prognostic Assessment for Sarah – Multiple Sclerosis
**Short-Term Prognosis (Days to Weeks):**
Sarah is at moderate risk for a relapse in the immediate future, given her recent MRI findings (gadolinium-enhancing lesions) and history of frequent relapses. Expect continued fatigue and potential for exacerbation of exi... | prognostic |
A 48-year-old Vietnamese-American female presents with confirmed disseminated histoplasmosis, diagnosed via bronchoalveolar lavage (BAL) culture and positive *Histoplasma* antigen in serum and urine. She initially presented with fever, cough, and fatigue 6 weeks ago. Imaging revealed bilateral pulmonary infiltrates and... | Disseminated histoplasmosis, despite initial antifungal therapy.
Persistent symptoms suggest treatment failure or complications.
Diabetes increases susceptibility to fungal infections.
Depression/anxiety impact adherence and recovery.
CD4 count moderately reduced, immune reconstitution unclear.
Vietnamese ethnicity: po... | # Prognostic Assessment: Disseminated Histoplasmosis
This 48-year-old female with disseminated histoplasmosis presents a complex prognostic challenge due to incomplete response to therapy, comorbidities, and psychosocial factors.
**Short-Term Prognosis (Days to Weeks):**
Guarded. The patient remains symptomatic desp... | prognostic |
Ethan, a 9-year-old male, presents with relapsed B-cell acute lymphoblastic leukemia (B-ALL). He was initially diagnosed 2 years ago and achieved complete remission after standard chemotherapy (ALL-BFM protocol). He relapsed with a blast count of 25% in the bone marrow 6 months ago and received blinatumomab followed by... | Relapsed B-ALL post-allo-HSCT indicates poor prognosis.
MRD+ status signifies increased relapse risk.
*KMT2A* rearrangement: high-risk genetic abnormality.
GVHD complicates post-transplant course, impacting outcomes.
Liver dysfunction suggests GVHD or disease involvement.
Asthma: potential for pulmonary complications d... | # Prognostic Assessment for Ethan – Relapsed B-ALL Post-Allo-HSCT
**Short-Term Prognosis (Days to Weeks):**
Ethan’s immediate prognosis is guarded. The combination of fever, worsening liver function, and MRD positivity suggests potential for rapidly progressive disease or severe GVHD complications. He is at high risk ... | prognostic |
A 2.5-year-old female presents with a history of severe food protein-induced enterocolitis syndrome (FPIES) triggered by rice, initially diagnosed at 6 months of age. She has experienced 5 prior FPIES reactions, each requiring emergency department visits for intravenous fluid resuscitation due to profuse vomiting and d... | FPIES severity: recurrent, ED visits indicate high risk.
Rice FPIES: challenging to manage, limited avoidance options.
Eczema: poorly controlled, barrier dysfunction increases sensitization.
Recurrent infections: suggests immune dysregulation, increased risk.
Growth faltering: malnutrition impacts immune development.
F... | # Prognostic Assessment for a 2.5-Year-Old with Severe FPIES
This case presents a complex scenario with multiple interacting factors influencing prognosis. The patient’s severe, recurrent FPIES, coupled with poorly controlled eczema, growth faltering, and recurrent respiratory infections, indicates a heightened risk f... | prognostic |
A 9-month-old female infant of Ashkenazi Jewish descent presents with progressively worsening bilateral hip instability diagnosed as late-presenting Developmental Dysplasia of the Hip (DDH). Initial ultrasound at 4 months showed a shallow acetabulum, but parents delayed follow-up due to logistical challenges and cultur... | Bilateral DDH, late presentation indicates poorer prognosis.
Severity: Grade III/II suggests significant acetabular dysplasia.
Family history increases risk of treatment failure.
Delayed diagnosis worsens potential for joint damage.
Delayed gross motor milestones indicate functional impairment.
Limited parental support... | # Prognostic Assessment: Bilateral Developmental Dysplasia of the Hip (DDH) in a 9-Month-Old Infant
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis depends on the response to initial treatment, likely a Pavlik harness. Successful reduction and stabilization within the first 2-6 weeks is crucial. Fai... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting for follow-up regarding advanced neovascular age-related macular degeneration (AMD) in both eyes. He was diagnosed 3 years ago and initially responded well to intravitreal anti-VEGF injections (aflibercept). However, over the past 6 months, his vision has progressi... | Advanced AMD, poor response to anti-VEGF, bilateral involvement.
Diabetes, hypertension, CKD worsen AMD progression risk.
Geographic atrophy indicates irreversible vision loss potential.
Rapid GA expansion suggests aggressive disease course.
Reduced eGFR impacts treatment options, increases complications.
Social isolat... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of advanced neovascular AMD with multiple factors impacting prognosis. His disease is progressing despite standard treatment, and his comorbidities and psychosocial situation further complicate the outlook.
**Short-Term Prognosis... | prognostic |
A 28-year-old female, previously healthy, presented 6 months ago with progressive dyspnea and a non-productive cough. Initial workup revealed pulmonary sarcoidosis confirmed by bilateral hilar lymphadenopathy on chest CT, ACE level elevation (85 U/L, normal <30 U/L), and bronchoalveolar lavage (BAL) with lymphocytic pr... | Sarcoidosis severity: moderate, progressive despite initial therapy.
Pulmonary hypertension: early stage, impacts exercise tolerance.
Cardiac involvement: palpitations suggest potential arrhythmia risk.
Prednisone side effects: consider long-term impact on health.
Functional status: declining, impacting daily activitie... | # Prognostic Assessment for Pulmonary Sarcoidosis
This 28-year-old female with pulmonary sarcoidosis presents a challenging prognostic scenario due to recurrent symptoms despite treatment, the development of pulmonary hypertension, and significant psychosocial stressors. Her case is complicated by the interplay of dis... | prognostic |
Mr. David Miller is a 52-year-old male with a 12-year history of Type 2 Diabetes Mellitus, poorly controlled (HbA1c consistently >9%). He was diagnosed with IgA nephropathy 5 years ago, initially mild, but has progressed to CKD Stage 4 (eGFR 22 ml/min/1.73m2, creatinine 3.8 mg/dL). He also has a history of ischemic hea... | CKD stage 4 indicates significant kidney function loss.
Poor diabetes control accelerates nephropathy progression.
Cardiovascular disease increases mortality risk significantly.
PAD complicates management and increases amputation risk.
High UPCR signifies ongoing glomerular damage.
Non-adherence worsens outcomes across... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case with multiple interacting conditions significantly impacting his prognosis. His IgA nephropathy, coupled with poorly controlled diabetes, cardiovascular disease, and peripheral artery disease, creates a high-risk scenario.
**Short-Term Pr... | prognostic |
A 6-month-old female infant presents with worsening respiratory distress. She was diagnosed with Severe Combined Immunodeficiency (SCID) due to ADA deficiency at 3 months following recurrent pneumonia and thrush unresponsive to standard treatment. She has received a matched unrelated donor hematopoietic stem cell trans... | SCID post-HSCT: complex, high-risk scenario.
aGVHD grade II impacts transplant success.
CMV viremia signifies immune reconstitution failure.
BOS stage 1 suggests early chronic lung damage.
Pre-transplant impaired function: poor baseline.
Corticosteroids increase infection susceptibility.
Parental support is a positive ... | # Prognostic Assessment for SCID Post-HSCT with aGVHD and CMV
This 6-month-old infant with SCID post-HSCT presents a highly complex prognostic challenge due to multiple interacting factors. Her prognosis is significantly guarded, requiring careful consideration of short, medium, and long-term outcomes.
**Short-Term P... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female with a history of longstanding Type 2 Diabetes Mellitus (diagnosed 20 years ago, poorly controlled - HbA1c 8.9%), hypertension (well-controlled on amlodipine 10mg daily), and chronic kidney disease stage 3a (eGFR 48 mL/min/1.73m2). She presents with acute limb ischemia of the... | Severe ischemia: limb viability acutely threatened.
Diabetes complicates wound healing, increases infection risk.
CKD stage 3a: impacts treatment options, recovery.
Prior MI: increased cardiovascular event probability.
Cognitive impairment: affects adherence, self-care.
Living alone: limited social support, increased v... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance faces a high risk of limb loss (amputation) within the next few weeks if definitive management isn't achieved, or if ischemia progresses. The immediate risk is driven by the severity of the acute limb ischemia and the l... | prognostic |
Mr. David Miller is a 52-year-old male presenting for follow-up regarding newly diagnosed Stage IIIB (T3N2M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology, confirmed by biopsy and PET/CT scan. He was a heavy smoker (60 pack-years) who quit 2 years ago. He reports increasing fatigue and a persistent coug... | Stage IIIB NSCLC indicates advanced, localized disease.
Smoking history significantly elevates recurrence risk.
ECOG 1 suggests moderate functional capacity.
Diabetes complicates treatment and recovery.
CKD impacts chemotherapy tolerance and side effects.
PD-L1 30% suggests potential immunotherapy benefit.
No driver mu... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller faces a moderate risk of acute toxicities from concurrent chemoradiation, including esophagitis, pneumonitis, fatigue, and myelosuppression. His CKD and diabetes increase the likelihood and severity of these side effects.... | prognostic |
A 2.5-year-old female of Ashkenazi Jewish descent presents with a confirmed diagnosis of Spinal Muscular Atrophy Type 1 (SMA1) diagnosed via genetic testing revealing biallelic SMN1 deletions. She initially presented at 6 months with generalized hypotonia and feeding difficulties. She currently requires tracheostomy an... | SMA1 severity: respiratory failure, early symptom onset.
Suboptimal gene therapy response: scoliosis progression noted.
Frequent infections: increased morbidity, mortality risk.
Nutritional compromise: impacts growth, immune function.
Psychosocial stress: affects adherence, support systems.
CK levels elevated: ongoing ... | # Prognostic Assessment for Spinal Muscular Atrophy Type 1
This 2.5-year-old female with SMA1 presents a complex prognostic challenge due to several factors impacting her expected trajectory. While early gene therapy was administered, the suboptimal response and ongoing disease progression necessitate a nuanced assess... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female with a history of well-controlled hypertension and osteoarthritis, presenting with newly diagnosed Stage IV Non-Small Cell Lung Cancer (NSCLC), adenocarcinoma histology. She was diagnosed after presenting with worsening dyspnea and a persistent cough. Imaging revealed a 4cm p... | Stage IV NSCLC inherently carries poor prognosis.
EGFR mutation suggests potential targeted therapy response.
Age 82 increases risk of treatment-related toxicity.
ECOG 1 indicates moderate functional reserve.
Anemia may limit treatment tolerance and quality of life.
Elevated ALP suggests potential liver metastasis burd... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance’s short-term prognosis is largely dependent on her response to initial treatment and management of symptoms. Without treatment, rapid symptom progression (dyspnea, cough, pain) is likely. With initiation of first-line E... | prognostic |
A 28-year-old female presents with a confirmed diagnosis of high-risk Acute Myeloid Leukemia (AML) with t(15;17) translocation (Acute Promyelocytic Leukemia - APL), currently in complete remission after induction chemotherapy with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). Initial WBC count was 85,000/µ... | APL remission status: favorable, but MRD positivity concerns.
t(15;17) translocation: generally good response to ATRA/ATO.
SLE comorbidity: increases infection risk, treatment complexity.
Prior DVT/aPL: ongoing thrombosis risk, anticoagulation needed.
Smoking history: worsens overall health, treatment tolerance.
Psycho... | # Prognostic Assessment for APL in Remission
This 28-year-old female with APL in remission presents a complex prognostic scenario due to interacting factors. While the t(15;17) translocation typically confers a favorable prognosis with ATRA/ATO therapy, several elements introduce significant uncertainty.
**Short-Term... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a 6-month history of progressive vision loss in both eyes. Initial examination revealed bilateral optic disc edema and peripapillary hemorrhages. MRI brain and orbits showed optic nerve enhancement consistent with neuro-inflammatory optic neuritis. She was i... | OPA1 mutation: severe, early-onset optic atrophy confirmed.
Bilateral involvement indicates aggressive disease course.
Rapid RNFL thinning suggests ongoing neurodegeneration.
AJIA comorbidity complicates treatment and prognosis.
Asthma: minimal direct impact on optic atrophy progression.
Psychological distress worsens ... | # Prognostic Assessment for OPA1-Related Optic Atrophy
This 9-year-old female with genetically confirmed autosomal recessive *OPA1*-related optic atrophy presents a complex prognostic challenge due to the interplay of genetic factors, disease severity, comorbid conditions, and psychosocial impact.
**Short-Term Progn... | prognostic |
A 2.5-year-old female presents with a confirmed diagnosis of severe Tetralogy of Fallot (TOF) status post complete surgical repair at 6 months of age. She now presents with progressively worsening cyanosis (SpO2 88-92% at rest), dyspnea on exertion, and fatigue. Echocardiogram reveals moderate pulmonary valve stenosis ... | TOF repair complications: PVS, RV dilation, fibrosis present.
Severe RV dysfunction indicated by elevated BNP and MRI.
Frequent infections suggest impaired immune function.
Cyanosis persists despite repair, limiting oxygen delivery.
Iron deficiency anemia exacerbates cardiac workload.
Family history of SCD raises arrhy... | # Prognostic Assessment for a 2.5-Year-Old Post-TOF Repair
This 2.5-year-old female with a history of Tetralogy of Fallot repair presents a complex prognostic challenge due to multiple interacting factors. Her case is considered high-risk.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis is guarded. ... | prognostic |
A 48-year-old G3P2 Caucasian female presents with a known diagnosis of Stage IIIC high-grade serous ovarian cancer, initially diagnosed 18 months ago. She underwent neoadjuvant chemotherapy (6 cycles of carboplatin and paclitaxel) followed by interval debulking surgery. Pathology post-surgery revealed residual disease ... | Stage IIIC recurrence indicates aggressive disease biology.
BRCA1 mutation suggests PARP inhibitor sensitivity initially.
Short olaparib maintenance limits long-term benefit.
Rising CA-125 confirms progressive disease activity.
ECOG 1 suggests moderate functional reserve.
Psychosocial distress impacts treatment adheren... | # Prognostic Assessment: Recurrent High-Grade Serous Ovarian Cancer
This 48-year-old patient with Stage IIIC high-grade serous ovarian cancer experiencing recurrence after initial response to platinum-based chemotherapy and PARP inhibitor maintenance presents a challenging prognostic scenario. Her case is complicated ... | prognostic |
A 9-year-old female presents with relapsed B-cell Acute Lymphoblastic Leukemia (B-ALL). Initial diagnosis at age 6 was high-risk B-ALL, Philadelphia chromosome negative, with a favorable *ETV6-RUNX1* fusion. She achieved complete remission after intensive chemotherapy following the ABL-0031 protocol. Relapse occurred 1... | Relapsed B-ALL indicates poorer overall survival potential.
Extramedullary relapse worsens prognosis significantly.
CNS relapse followed by extramedullary disease is high-risk.
MRD positivity (5%) suggests incomplete remission.
Asthma, mild delay: impact treatment tolerance/quality of life.
Family history of CVD: poten... | # Prognostic Assessment for Relapsed B-ALL
This 9-year-old female with relapsed B-ALL presents a complex prognostic scenario. Her initial favorable genetic feature (*ETV6-RUNX1*) is overshadowed by the pattern of relapse and current disease burden.
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is ... | prognostic |
A 6-month-old female infant presents with confirmed congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, salt-wasting form. Diagnosis was made at 2 weeks of age following a salt-wasting crisis presenting with vomiting, dehydration, and hyponatremia. Genetic testing revealed two pathogenic variants: c.... | Salt-wasting CAH indicates severe enzyme deficiency.
Suboptimal cortisol response suggests inadequate glucocorticoid dosing.
Frequent hyponatremia signals poor mineralocorticoid control.
Delayed bone age indicates growth hormone/glucocorticoid impact.
Poor growth velocity raises long-term height concerns.
Maternal anxi... | # Prognostic Assessment: Congenital Adrenal Hyperplasia (CAH) - Salt-Wasting Form
This 6-month-old female with salt-wasting CAH presents a complex prognostic challenge due to multiple high-risk factors and suboptimal control despite treatment. Her genetic compound heterozygosity (c.844G>T and c.1720A>G) suggests signi... | prognostic |
Mrs. Elara Vance is a 93-year-old Caucasian female admitted for management of recurrent uterine bleeding. She has a history of well-controlled hypertension, type 2 diabetes mellitus (managed with metformin), and mild cognitive impairment (MCI) diagnosed 3 years ago. She lives alone, with daily assistance from a home he... | Advanced age significantly impacts treatment tolerance.
Stage I, Grade 1 suggests favorable initial prognosis.
Comorbidities (HTN, DM, MCI) increase risk of complications.
Frailty (Katz 4/7) limits functional reserve.
Anemia (Hb 8.5) worsens fatigue and functional decline.
*TP53* mutation suggests aggressive tumor biol... | # Prognostic Assessment for Mrs. Elara Vance
**Established Diagnosis:** Stage I, Grade 1 Endometrioid Adenocarcinoma of the endometrium with *TP53* mutation.
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance’s short-term prognosis is guarded, primarily due to her anemia and frailty. The risk of complications from ... | prognostic |
An 8-year-old male, previously healthy, presents 6 months post-left femur physeal fracture sustained during a motor vehicle accident. Initial treatment involved closed reduction and spica casting. Radiographs at 3 months showed non-union with significant angular deformity (approximately 30 degrees valgus). He underwent... | Established non-union, post-ORIF, complicated by chronic infection.
Cerebral palsy impacts functional recovery and rehabilitation.
Leg length discrepancy worsens gait and joint loading.
SSI presence delays healing and increases re-operation risk.
Poor socioeconomic status limits access to optimal care.
Inconsistent PT ... | # Prognostic Assessment: Pediatric Femur Non-Union with Chronic Osteomyelitis & Cerebral Palsy
This 8-year-old boy presents a complex orthopedic case with multiple factors influencing his prognosis. His established femur non-union, complicated by chronic *Staphylococcus aureus* osteomyelitis, and co-existing cerebral ... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female with a history of Stage IV Non-Small Cell Lung Cancer (NSCLC) – adenocarcinoma, initially diagnosed 6 months ago. She presented with progressive dyspnea and a persistent cough. Initial staging revealed T2aN3M1 disease with metastases to the brain and bone. She received first-... | Advanced NSCLC with brain and bone metastases.
Prior chemotherapy failure indicates resistance.
Poor performance status (ECOG 2) worsens outlook.
Comorbidities (diabetes, CKD) increase risk.
Elevated LDH suggests aggressive disease course.
Cognitive impairment impacts treatment decisions.
Limited social support complic... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance’s short-term prognosis is guarded. Her progressive disease, escalating pain requiring higher opioid doses, and declining functional status suggest a high risk of symptom exacerbation and potential complications such as ... | prognostic |
Mr. David Chen, a 48-year-old Vietnamese-American male, presents with confirmed disseminated histoplasmosis. He was diagnosed 3 weeks ago after presenting with fever, cough, weight loss (15lbs in 2 months), and fatigue. Initial workup revealed bilateral hilar lymphadenopathy on chest CT, positive *Histoplasma* antigen ... | Disseminated histoplasmosis indicates severe systemic infection.
Diabetes impairs immune function, worsening prognosis.
CKD stage 3 increases treatment toxicity risk.
Elevated antigen titers suggest incomplete response.
Southeast Asian ethnicity: increased susceptibility, severity.
Financial stress impacts adherence, o... | # Prognostic Assessment for Disseminated Histoplasmosis in Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen’s short-term prognosis is guarded. While he is receiving appropriate antifungal therapy, his persistent symptoms (fatigue, cough) and only modest decline in *Histoplasma* antigen titers suggest ... | prognostic |
A 9-year-old female of mixed African and European ancestry presents with a 3-year history of generalized vitiligo, initially presenting as small, depigmented macules on her hands and feet. The disease has progressed significantly, now affecting >60% of her body surface area (BSA), including facial involvement (perioral... | Generalized vitiligo, >60% BSA, indicates severe disease.
Early onset, extensive involvement suggests poorer prognosis.
Family history of autoimmunity increases risk of progression.
Subclinical hypothyroidism: potential for thyroid autoimmunity.
PTPN22 polymorphism: increased autoimmune disease susceptibility.
Facial i... | # Prognostic Assessment for Generalized Vitiligo
This 9-year-old female with generalized vitiligo presents a complex case requiring careful prognostic assessment. Her disease severity, genetic predisposition, autoimmune comorbidities, and psychosocial impact all contribute to a guarded prognosis.
**Short-Term Prognos... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of Stage III (T3N1M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He completed 6 cycles of cisplatin/pemetrexed chemotherapy, with partial response noted on imaging 3 months ago. He presents to the pre-operative clinic ... | NSCLC stage III, partial response, impacts surgical candidacy.
Severe COPD significantly elevates perioperative pulmonary risk.
Cardiac history increases risk of perioperative cardiovascular events.
Diabetes impairs wound healing, increases infection risk.
Decreased albumin suggests malnutrition, poor reserve.
ECOG 2 i... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon faces a high risk of perioperative morbidity and mortality. The primary concerns are respiratory failure, cardiac complications (arrhythmia, MI), surgical site infection, and delirium. The risk of 30-day mortalit... | prognostic |
A 52-year-old African American female, Ms. Evelyn Reed, presents with pathologically confirmed Stage IIIB (T3N2M0) HER2-positive invasive ductal carcinoma of the left breast, diagnosed 6 months ago. She initially underwent neoadjuvant chemotherapy (AC-T regimen) followed by lumpectomy and sentinel lymph node biopsy rev... | Stage IIIB HER2+ breast cancer: aggressive disease.
BRCA1 mutation: increased recurrence risk.
Residual disease post-chemotherapy: poor response.
Positive lymph nodes: higher metastatic potential.
Rising CA 15-3: suggests disease progression.
New lung nodule: potential distant metastasis.
Comorbidities (HTN, DM): impac... | # Prognostic Assessment for Ms. Evelyn Reed
Ms. Reed presents a complex case with multiple high-risk features impacting her prognosis. Her Stage IIIB HER2-positive breast cancer, despite initial treatment, demonstrates concerning signs of potential progression.
**Short-Term Prognosis (Days to Weeks):**
Her immediate ... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a 2-year history of severe, refractory asthma, initially diagnosed at age 7. She experiences frequent exacerbations (average 6 per year) requiring systemic corticosteroids (prednisone bursts, typically 1mg/kg for 5-7 days). Despite high-dose inhaled corticos... | Severe asthma, frequent exacerbations indicate poor control.
Early onset, corticosteroid resistance: concerning prognostic indicators.
CFTR heterozygosity suggests potential airway dysfunction.
Recurrent infections worsen lung damage, impact prognosis.
Elevated IgE, eosinophils suggest Th2-high inflammation.
Family his... | # Prognostic Assessment for Refractory Childhood Asthma
This 9-year-old female with severe, refractory asthma presents a complex prognostic challenge. Her disease course is characterized by multiple high-risk factors, and limited evidence exists to guide precise predictions.
**Short-Term Prognosis (Days to Weeks):**
... | prognostic |
A 72-year-old female, Mrs. Eleanor Vance, presents with a known diagnosis of Parkinson’s Disease (PD) established 8 years ago, currently Hoehn & Yahr stage III. She initially presented with right-sided tremor and rigidity, which has progressed to involve the left side with noticeable bradykinesia and postural instabili... | PD stage III indicates moderate disease severity.
Age >70 increases risk of faster progression.
Comorbid diabetes impacts neuroinflammation, progression.
Recent fracture suggests increased fall risk, morbidity.
Executive dysfunction predicts poorer functional outcomes.
Apathy correlates with reduced treatment adherence... | # Prognostic Assessment for Mrs. Eleanor Vance
Mrs. Vance presents a complex case with multiple interacting factors influencing her prognosis. Her established Parkinson’s Disease, complicated by comorbidities, recent fracture, and emerging cognitive and functional decline, necessitates a nuanced assessment.
**Short-T... | prognostic |
A 7-day-old female infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress. She was diagnosed with Hypoplastic Left Heart Syndrome (HLHS) via prenatal echocardiography. Postnatally, she was maintained on prostaglandin E1 (PGE1) infusion. Initial echocardiogram confirmed sev... | HLHS severity: critical, requiring staged reconstruction.
Prematurity increases risk of complications significantly.
Metabolic acidosis indicates poor tissue perfusion.
NOTCH1 mutation: elevated dissection risk post-surgery.
Maternal diabetes: impacts fetal cardiac development.
Roma ethnicity: potential healthcare acce... | # Prognostic Assessment for Neonate with HLHS
This 7-day-old female with HLHS presents a complex prognostic challenge due to multiple interacting factors. Her prognosis is significantly guarded, requiring a nuanced assessment across short, medium, and long-term horizons.
**Short-Term Prognosis (Days to Weeks):**
The... | prognostic |
A 16-year-old Hispanic female, Maria, presents to the emergency department 48 hours after intentional ingestion of a large quantity of diphenhydramine (estimated 2g) in a suicide attempt following a recent breakup with her boyfriend and ongoing bullying at school. She has a history of mild intermittent asthma, controll... | Diphenhydramine ingestion: high dose, significant anticholinergic effects.
QTc prolongation: concerning for torsades de pointes risk.
Renal function mildly impaired, potential for drug accumulation.
Hepatic transaminitis: suggests potential liver injury.
Psychiatric history: anxiety, depression, inconsistent medication... | # Prognostic Assessment for Diphenhydramine Overdose in Maria
**Diagnosis:** Diphenhydramine overdose with anticholinergic toxidrome, complicated by QTc prolongation, mild renal and hepatic impairment, and underlying psychiatric illness.
**Short-Term Prognosis (Days to Weeks):**
Maria’s immediate prognosis is guarded... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted to the ICU with severe pneumonia secondary to multi-drug resistant *Pseudomonas aeruginosa*. He has a history of COPD (GOLD Stage 3, frequent exacerbations), poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), chronic kidney disease stage 3 (eGFR 45 mL/min/1.73m... | Severe pneumonia, multi-drug resistance complicates treatment.
Advanced COPD increases risk of respiratory failure.
Diabetes impairs immune function, slows healing.
CKD impacts drug metabolism, increases infection risk.
Hip fracture limits functional recovery potential.
Social isolation hinders support, adherence to ca... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple comorbidities significantly impacting his prognosis. His severe pneumonia caused by a multi-drug resistant organism, coupled with pre-existing conditions and limited social support, paints a concerning picture.
**Sh... | prognostic |
Mr. Elias Vance is an 82-year-old African American male presenting for follow-up regarding advanced neovascular age-related macular degeneration (AMD) in both eyes. He was diagnosed 5 years ago and initially responded well to intravitreal anti-VEGF injections (ranibizumab). However, over the past year, his vision has p... | Advanced AMD, persistent fluid, declining vision, poor response.
Age, genetics, diabetes, cognitive impairment: increased risk.
Anti-VEGF resistance common, limits treatment effectiveness.
Geographic atrophy indicates irreversible macular damage.
Poor glycemic control exacerbates AMD progression.
Cognitive decline impa... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of advanced neovascular AMD with multiple interacting factors influencing his prognosis. His age, genetic predisposition, poorly controlled diabetes, cognitive impairment, and social isolation all contribute to a guarded outlook.
**Short-Te... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents for follow-up 6 months post-partum. She was diagnosed with Peripartum Cardiomyopathy (PPCM) – dilated cardiomyopathy with severely reduced ejection fraction (EF 25%) – three weeks post-delivery. Her pregnancy was uncomplicated until late third trimester when she developed... | PPCM severity: severely reduced EF, NYHA III symptoms.
Postpartum timing: beyond 6 months, recovery less likely.
MR severity: moderate MR worsens heart failure symptoms.
BNP level: elevated, indicates ongoing myocardial stress.
Family history: premature CAD suggests genetic predisposition.
Comorbidities: asthma and anx... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of PPCM with several factors influencing her prognosis. Her severely reduced EF, persistent symptoms despite GDMT, and moderate MR indicate a high-risk profile.
**Short-Term Prognosis (Days to Weeks):** Ms. Sharma is at risk for acute deco... | prognostic |
A 52-year-old African American female with a 20-pack-year smoking history presents to the ICU following a motor vehicle collision. She sustained a traumatic brain injury (TBI) – diffuse axonal injury (DAI), classified as severe (GCS 6 post-resuscitation, improving to 8). She also has a right femur fracture and multiple... | Severe TBI impacts neurological recovery potential.
Comorbid diabetes worsens TBI outcomes significantly.
CKD increases infection risk, complicates management.
Carbapenem-resistant bacteria: treatment is challenging.
APOE4 allele linked to poorer cognitive outcomes.
Atrial fibrillation increases stroke and mortality ri... | # Prognostic Assessment for Patient with Severe TBI and Comorbidities
This 52-year-old female presents a complex case with multiple interacting factors significantly impacting her prognosis. Her severe DAI, coupled with significant comorbidities, creates a high-risk scenario.
**Short-Term Prognosis (Days to Weeks):**... | prognostic |
A 16-year-old male presents with a 3-year history of severe, recalcitrant nodular acne conglobata affecting his face, chest, back, and buttocks. Diagnosis confirmed by biopsy showing extensive neutrophilic infiltrate and follicular rupture. He has failed multiple courses of oral antibiotics (tetracycline, doxycycline, ... | Severe acne conglobata indicates aggressive disease course.
Isotretinoin failure suggests treatment resistance.
Crohn’s disease complicates systemic inflammation management.
Prednisone flares worsen acne and increase infection risk.
Depression impacts adherence and overall wellbeing.
Scarring signifies prolonged inflam... | # Prognostic Assessment: Severe Nodular Acne Conglobata with Comorbidities
This 16-year-old male with severe nodular acne conglobata presents a complex prognostic challenge due to the interplay of his dermatological condition, Crohn’s disease, mental health issues, and treatment history. His case is considered high-ri... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male with a 15-year history of severe, uncontrolled asthma, currently classified as Step 5 therapy (omalizumab, high-dose inhaled corticosteroids/LABA). He presents with worsening dyspnea and a productive cough despite maximal medical therapy. He was diagnosed with... | Severe asthma complicates IPF prognosis significantly.
IPF progression accelerated by *MUC5B* variant.
Recent fracture limits functional capacity.
Social isolation impacts adherence and outcomes.
Right heart strain indicates advanced disease.
Weight loss suggests disease progression/cachexia.
Age 82 increases vulnerabi... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case with multiple interacting conditions significantly impacting his prognosis. His combination of severe asthma, rapidly progressive IPF, and multiple comorbidities creates a high-risk scenario.
**Short-Term Prognosis (Days to Weeks):**
Mr... | prognostic |
Ms. Anya Sharma, a 48-year-old Filipina woman, presents for follow-up regarding Stage IIIB (T3N2M0) HER2-positive invasive ductal carcinoma of the left breast, diagnosed 6 months ago. She completed neoadjuvant chemotherapy (AC-T regimen) followed by lumpectomy and sentinel lymph node biopsy revealing 2 positive nodes. ... | Stage IIIB HER2+ breast cancer: aggressive disease.
BRCA1 mutation: increased recurrence risk.
Positive lymph nodes: higher metastatic potential.
Cardiac dysfunction: limits treatment options.
Diabetes & hypertension: comorbidities impact healing.
Depression & social isolation: affect adherence.
Rising CA 15-3: potenti... | # Prognostic Assessment for Ms. Anya Sharma
**Short-Term Prognosis (Days to Weeks):**
Ms. Sharma’s short-term prognosis is relatively stable, assuming no acute complications from her treatment or disease. The primary concern is managing her increasing fatigue and shoulder pain. The rising CA 15-3 warrants investigatio... | prognostic |
Mr. Elias Vance is a 72-year-old African American male with a history of Child-Pugh C cirrhosis secondary to chronic Hepatitis C (genotype 1a) and alcohol use disorder (currently abstinent for 6 months). He presented 3 days ago with altered mental status and ascites worsening over the past week. Initial workup revealed... | Cirrhosis severity: Child-Pugh C indicates advanced liver disease.
SBP complicates cirrhosis, increasing mortality significantly.
HRS-AKI worsens prognosis, indicating end-organ failure.
High MELD-Na score (28) predicts short-term mortality.
Diabetes and CAD increase cardiovascular risk and complications.
PNPLA3 genoty... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case with multiple interacting factors contributing to a guarded prognosis. His advanced cirrhosis, complicated by SBP and HRS-AKI, places him at high risk for near-term mortality.
**Short-Term Prognosis (Days to Weeks):**
His immediate prognosi... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a history of diabetic nephropathy (Stage 4 CKD, eGFR 22 ml/min/1.73m2, albuminuria 1.5g/day) presenting with worsening lower extremity edema and shortness of breath. He was diagnosed with Type 2 Diabetes 25 years ago, poorly controlled with HbA1c consistently between 8.... | Stage 4 CKD significantly impacts overall survival.
Diabetes accelerates CKD progression, poor control worsens.
Cardiovascular disease is a leading cause of mortality.
Functional decline predicts adverse outcomes in CKD.
Hyperkalemia indicates advanced kidney dysfunction.
Anemia contributes to fatigue and cardiac strai... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Established Diagnosis:** Stage 4 Diabetic Nephropathy with significant comorbidities.
**Short-Term Prognosis (Days to Weeks):** Mr. Penhaligon is at high risk for near-term complications. The hyperkalemia requires immediate management to prevent cardiac arrhythmias.... | prognostic |
A 16-year-old female of mixed African and European ancestry presents with a 6-month history of worsening systemic lupus erythematosus (SLE). Diagnosis was confirmed 3 months ago based on meeting 4/11 ACR criteria (malar rash, serositis, cytopenias – hemolytic anemia and thrombocytopenia, and positive anti-dsDNA antibod... | SLE severity: active, proliferative nephritis, refractory to initial therapy.
Renal involvement: significant proteinuria, Class IV nephritis, poor prognosis.
High anti-dsDNA: correlates with disease activity and flares.
Low complement C3: indicates active inflammation, renal risk.
Anti-Ro/SSA: associated with neonatal ... | # Prognostic Assessment for Systemic Lupus Erythematosus (SLE)
This 16-year-old female with SLE presents a complex case with multiple high-risk features, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis is guarded. The active lupus nephritis (Class IV) ... | prognostic |
Mrs. Eleanor Vance is a 93-year-old female with a recently confirmed diagnosis of relapsing-remitting multiple sclerosis (RRMS) that transitioned to secondary progressive MS (SPMS) approximately 5 years ago. She presented with worsening gait instability and new-onset urinary incontinence. MRI shows significant cerebral... | SPMS indicates progressive neurological deterioration.
Advanced age significantly impacts recovery potential.
High EDSS score reflects substantial disability.
Cognitive impairment complicates management, adherence.
Comorbidities worsen overall health, prognosis.
Low albumin suggests malnutrition, frailty risk.
Social i... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance is at high risk for falls and related injuries (fractures, head trauma) due to her gait instability and declining functional status. She is also susceptible to urinary tract infections (UTIs) secondary to incontinence, ... | prognostic |
An 8-year-old female presents with a confirmed diagnosis of Legg-Calvé-Perthes Disease (LCPD) affecting her left hip. Initial presentation was 6 months ago with left groin and thigh pain, limping, and decreased range of motion. Radiographs demonstrated early avascular necrosis. She is currently classified as a Stulberg... | LCPD stage II indicates moderate disease severity.
Cerebral palsy adds complexity to hip development.
Obesity increases mechanical stress on the hip joint.
Family history suggests genetic predisposition to arthritis.
Vitamin D deficiency impacts bone health and healing.
Reduced functional status pre-disease is concerni... | # Prognostic Assessment for Legg-Calvé-Perthes Disease (LCPD) in a Child with Cerebral Palsy
This 8-year-old female with LCPD, complicated by cerebral palsy, obesity, and Vitamin D deficiency, presents a challenging prognostic scenario. Her prognosis requires careful consideration of multiple interacting factors.
**S... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting to the Emergency Department with worsening shortness of breath. He has a known history of Stage III Chronic Obstructive Pulmonary Disease (GOLD classification) complicated by frequent exacerbations, poorly controlled Type 2 Diabetes Mellitus (HbA1c ... | COPD exacerbation severity: moderate-severe, high risk.
Diabetes impacts healing, increases infection susceptibility.
Prior MIs suggest cardiac reserve limitations.
CKD stage 3a: increased mortality, slower recovery.
Recent pneumonia: potential for secondary infection.
Age 82: physiological reserve significantly dimini... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case with multiple interacting comorbidities significantly impacting his prognosis. His COPD exacerbation is the acute driver, but his underlying conditions dramatically modify the expected outcome.
**Short-Term Prognosis (Days to Weeks):**
... | prognostic |
An 8-year-old female presents with a known diagnosis of Juvenile Nasopharyngeal Fibrosarcoma (JNF), confirmed by biopsy and immunohistochemistry (positive for EMA, vimentin, and negative for desmin). Initial presentation 6 months ago included nasal obstruction, epistaxis, and left facial swelling. Imaging revealed a lo... | JNF recurrence post-treatment indicates aggressive disease biology.
Orbital involvement signifies advanced local disease progression.
Incomplete initial response to chemotherapy is concerning.
Developmental delay impacts treatment adherence and recovery.
Asthma, well-controlled, poses minimal immediate risk.
Psychosoci... | # Prognostic Assessment: Juvenile Nasopharyngeal Fibrosarcoma Recurrence
This 8-year-old female with recurrent JNF presents a complex prognostic challenge. Her initial presentation with locally advanced disease (T3N1M0) and incomplete response to neoadjuvant chemotherapy established a higher risk profile from the outs... | prognostic |
Mr. Elias Vance, a 68-year-old African American male, presents with established chronic mercury poisoning from artisanal gold mining exposure over 30 years. He initially presented 6 months ago with insidious onset of tremor, paresthesias, cognitive decline (MMSE 22/30), and gingivitis. Initial blood mercury level was 1... | Established chronic mercury poisoning, neurological symptoms present.
High initial mercury levels, incomplete chelation response.
CKD stage 3 complicates chelation, increases toxicity risk.
Diabetes exacerbates neuropathy, impacts overall health.
*SLC7A13* genotype predicts slower detoxification, worse outcome.
Cogniti... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of chronic mercury poisoning with multiple high-risk factors, making accurate prognosis challenging. His established neurological deficits, genetic predisposition, and comorbidities significantly impact his expected trajectory.
**Short-Term... | prognostic |
Mr. David Miller is a 52-year-old male presenting with a known diagnosis of Chronic Myeloid Leukemia (CML) in chronic phase, diagnosed 3 years ago. He initially responded well to first-line imatinib therapy, achieving a complete cytogenetic response within 6 months. However, over the past 6 months, he has experienced i... | Accelerated phase CML signifies worsening disease burden.
T315I mutation limits treatment options significantly.
Prior MI increases cardiovascular risk during therapy.
Diabetes complicates treatment tolerance and recovery.
Rising BCR-ABL1 indicates imatinib resistance progression.
ECOG 1 suggests relatively good functi... | # Prognostic Assessment for Mr. David Miller – Accelerated Phase CML with T315I Mutation
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at immediate risk of progressing to blast crisis. Without rapid intervention, the increasing blast percentage (15%) suggests a high probability of acute leukemia transformati... | prognostic |
Mr. David Chen, a 48-year-old Asian male, presents 6 months post-operatively following a type IIIA open tibial fracture sustained in a motor vehicle accident. Initial management included irrigation, debridement, and retrograde nailing. He developed a grade IIIB open fracture with significant soft tissue loss requiring ... | Open fracture severity: Type IIIA/IIIB significantly impacts healing.
Diabetes impairs bone healing and increases infection risk.
Smoking reduces blood flow, hindering fracture union.
Infection history complicates prognosis, potential for recurrence.
Non-union presence indicates prolonged healing impairment.
COL1A1 het... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen faces a high risk of continued pain and functional decline in the immediate future. Without intervention, the non-union is unlikely to heal spontaneously. There is a moderate risk of further complications related to the hardw... | prognostic |
Mr. Elias Vance, a 72-year-old African American male, presents with established severe acetaminophen-induced hepatotoxicity following a deliberate overdose (18g) taken 48 hours prior. He has a history of poorly controlled Type 2 Diabetes Mellitus (HbA1c 9.2%), chronic kidney disease stage 3 (eGFR 45 mL/min/1.73m2), and... | Acetaminophen toxicity: severe, delayed presentation, high dose.
CKD stage 3 worsens liver injury, limits NAC efficacy.
Diabetes impairs liver regeneration, increases infection risk.
HFpEF complicates fluid management, increases cardiovascular stress.
High MELD score indicates significant liver dysfunction, mortality.
... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of severe acetaminophen-induced hepatotoxicity complicated by significant comorbidities and psychosocial factors, making accurate prognosis challenging. His prognosis is guarded, with risks spanning short, medium, and long-term horizons.
**... | prognostic |
A 6-month-old male infant presents with a confirmed diagnosis of Juvenile Myelomonocytic Leukemia (JMML) following bone marrow aspiration and cytogenetic analysis revealing a *RAS* pathway mutation (specifically *NRAS* Q61R). He initially presented with hepatosplenomegaly, pallor, and recurrent infections. Initial WBC ... | JMML severity: high WBC, monocytosis, organomegaly present.
RAS mutation: unfavorable prognostic marker in JMML.
Neurodevelopmental delay: impacts quality of life, treatment tolerance.
Prior bronchiolitis: suggests impaired pulmonary reserve.
Poor weight gain: indicates nutritional compromise, frailty.
Platelet count: ... | # Prognostic Assessment for Infant with JMML
This 6-month-old infant with JMML presents a complex prognostic scenario due to multiple interacting risk factors and comorbidities. His *NRAS*-mutated JMML, coupled with pre-existing neurodevelopmental delay and a history of severe respiratory illness, significantly compli... | prognostic |
A 28-year-old African American male with a history of sickle cell disease (HbSS genotype) presents to the Emergency Department with acute chest syndrome (ACS) triggered by a respiratory infection (confirmed influenza A). He reports worsening dyspnea, pleuritic chest pain, and a dry cough for 3 days. He has a history of... | Sickle cell ACS severity: moderate to high risk.
Acute kidney injury complicates ACS management.
Influenza exacerbates vaso-occlusion and hypoxia.
Smoking worsens lung function, increases ACS risk.
Poor hydroxyurea adherence impacts disease control.
Social isolation hinders supportive care access.
Baseline restrictive ... | # Prognostic Assessment for Acute Chest Syndrome in Sickle Cell Disease
This 28-year-old male with sickle cell disease and ACS presents a complex prognostic challenge due to multiple interacting risk factors and comorbidities. His prognosis needs to be considered across short, medium, and long-term horizons.
**Short-... | prognostic |
A 9-month-old female infant of Ashkenazi Jewish descent presents with a rapidly enlarging abdominal mass discovered by her mother during routine diaper changes. Initial evaluation revealed hepatosplenomegaly and pallor. Biopsy confirmed Stage IV neuroblastoma, MYCN amplified, originating from the adrenal gland. Genetic... | Stage IV neuroblastoma indicates aggressive disease course.
MYCN amplification signifies poor prognosis, rapid progression.
ALK mutation suggests potential targeted therapy response.
Bone marrow involvement worsens prognosis significantly.
High LDH and ferritin indicate extensive tumor burden.
Prematurity/CLD increases... | # Prognostic Assessment for Stage IV Neuroblastoma in a 9-Month-Old Infant
**Short-Term Prognosis (Days to Weeks):**
Guarded. The infant is at high risk for rapid disease progression and treatment-related complications. Immediate concerns include managing tumor lysis syndrome (given high LDH and ferritin), cytopenias ... | prognostic |
A 28-year-old female presents to the ED with worsening shortness of breath and lower extremity edema. She was diagnosed with Peripartum Cardiomyopathy (PPCM) six months postpartum following her first pregnancy. Initial ejection fraction (EF) was 30%. She was started on guideline-directed medical therapy (GDMT) includin... | PPCM severity: significantly reduced EF, worsening symptoms.
Postpartum timing: beyond initial 6-month recovery window.
BNP elevation: indicates ongoing cardiac stress/failure.
Renal function decline: suggests cardiorenal syndrome risk.
Hypokalemia: diuretic-induced, arrhythmia potential.
Comorbid gestational diabetes:... | # Prognostic Assessment for Peripartum Cardiomyopathy
This 28-year-old female with PPCM presents a complex prognostic challenge due to multiple interacting factors. Her condition has progressed despite initial GDMT, indicating a higher risk profile.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis is... | prognostic |
A 28-year-old African American female with a 7-year history of severe, uncontrolled asthma presents for a follow-up appointment. Her asthma is characterized by frequent exacerbations (average 4 per year requiring oral corticosteroids), nocturnal symptoms 5-7 nights/week, and significant limitations in physical activity... | Severe asthma, frequent exacerbations indicate poor control.
ICU admissions suggest high risk of future events.
Low FEV1 signifies significant airflow obstruction.
ORMDL3 mutation predicts corticosteroid resistance.
Smoking worsens airway inflammation and disease progression.
Comorbid anxiety/depression impacts self-ma... | # Prognostic Assessment for Severe Asthma
This 28-year-old African American female with severe asthma presents a complex case with a concerning prognosis. Her disease is characterized by multiple high-risk factors and significant comorbidities.
**Short-Term Prognosis (Days to Weeks):**
High risk of acute exacerbation... | prognostic |
A 7-day-old male infant, born at 28 weeks gestation (birth weight 950g), initially presented with respiratory distress syndrome requiring surfactant administration and mechanical ventilation. He developed late-onset sepsis on day 5, confirmed by positive blood culture growing *Klebsiella pneumoniae* carbapenemase-produ... | Extreme prematurity significantly increases mortality risk.
KPC-Kp sepsis: high mortality, treatment challenges.
NEC stage II: surgical intervention likely needed.
Renal dysfunction worsens overall prognosis significantly.
Thrombocytopenia suggests ongoing systemic inflammation.
Persistent ventilation indicates severe ... | # Prognostic Assessment for Neonate with KPC-Kp Sepsis, NEC, and Prematurity
This extremely premature infant with multi-organ dysfunction following KPC-Kp sepsis and NEC faces a grave prognosis. The interplay of prematurity, antibiotic-resistant infection, gastrointestinal pathology, and renal impairment creates a com... | prognostic |
A 9-year-old female of mixed African-American and Ashkenazi Jewish descent presents with relapsed B-cell Acute Lymphoblastic Leukemia (B-ALL). She was initially diagnosed 2 years ago with standard-risk B-ALL and completed frontline therapy (ALL-BFM protocol) achieving morphological remission. Relapse occurred in the bo... | Relapsed B-ALL post-allo-HSCT: poor initial prognostic factor.
Positive MRD post-transplant indicates persistent disease burden.
Extensive chronic GVHD complicates treatment and survival.
TP53 mutation: increased leukemia risk and treatment resistance.
Cytopenias increase infection risk, impacting quality of life.
Asth... | # Prognostic Assessment for Relapsed B-ALL Post-Allo-HSCT
This 9-year-old patient with relapsed B-ALL following allo-HSCT presents a complex prognostic scenario. Multiple adverse factors significantly impact her outlook.
**Short-Term Prognosis (Days to Weeks):**
Guarded. The patient is at high risk for opportunistic ... | prognostic |
A 48-year-old African American female, Ms. Evelyn Reed, presents with Stage IV HER2-positive metastatic breast cancer. Initial diagnosis was 3 years ago with a primary tumor in the left breast. She initially responded well to neoadjuvant chemotherapy (AC-T) followed by surgery and radiation. Two years post-treatment, s... | Stage IV HER2+ breast cancer: inherently poor prognosis.
BRCA1 mutation: potential sensitivity to PARP inhibitors.
Visceral crisis (liver mets): accelerates disease progression.
Bone metastases: pain, fracture risk, morbidity increase.
Diabetes, CKD, hypertension: comorbidities complicate care.
ECOG 2: limited function... | # Prognostic Assessment for Ms. Evelyn Reed
Ms. Reed presents a complex case with multiple factors influencing her prognosis. Her Stage IV HER2-positive breast cancer, despite initial response to therapy, is now demonstrating aggressive progression. The presence of visceral metastases (liver) and bone involvement sign... | prognostic |
A 7-day-old female infant, born at 32 weeks gestation (birth weight 1.6kg), presents with progressively worsening respiratory distress. She was diagnosed with Neonatal Alloimmune Thrombocytopenia (NAIT) secondary to maternal anti-HPA-1a antibodies. Initial platelet count was 10 x 10^9/L. She received first-line IVIG tr... | Severe thrombocytopenia increases hemorrhage risk significantly.
Prematurity contributes to IVH and neurodevelopmental delay.
Grade 2 IVH predicts neurological sequelae probability.
Renal impairment complicates fluid management and recovery.
CNS bacteremia adds infection-related morbidity/mortality risk.
Maternal pre-e... | # Prognostic Assessment: Neonatal Alloimmune Thrombocytopenia with Comorbidities
This case presents a complex scenario with a newborn infant facing multiple interacting challenges, significantly impacting her prognosis. The primary diagnosis of NAIT is complicated by prematurity, IVH, renal impairment, sepsis, and psy... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a confirmed diagnosis of Juvenile Nasopharyngeal Undifferentiated Sinonasal Carcinoma (JNU-USC), Stage III. Initial presentation included nasal obstruction, epistaxis, and left facial swelling. Biopsy revealed poorly differentiated carcinoma, positive for MY... | JNU-USC, Stage III: inherently aggressive malignancy.
MYC rearrangement: strong indicator of poor prognosis.
Perineural invasion: increased risk of local recurrence.
Cavernous sinus proximity: complicates surgical resection.
ECOG 1: relatively good functional status initially.
Asthma: potential chemotherapy treatment l... | # Prognostic Assessment for Juvenile Nasopharyngeal Undifferentiated Sinonasal Carcinoma (JNU-USC)
This 9-year-old female with Stage III JNU-USC presents a complex prognostic scenario. Her disease is characterized by several high-risk features, necessitating a detailed and nuanced assessment.
**Short-Term Prognosis (... | prognostic |
Mr. David Lee is a 52-year-old African American male admitted to the ICU following a motor vehicle collision. He sustained a traumatic brain injury (TBI) – diffuse axonal injury (DAI), classified as severe based on GCS of 6 initially, now 8 after 24 hours. He also has a left femur fracture and multiple rib fractures wi... | Severe TBI impacts neurological recovery potential.
CKD stage 3 increases infection and complication risk.
Diabetes impairs healing and immune function significantly.
APOE4 genotype linked to worse TBI outcomes.
Smoking exacerbates cardiovascular and pulmonary issues.
Age increases vulnerability to TBI complications.
P... | # Prognostic Assessment for Mr. David Lee
**Short-Term Prognosis (Days to Weeks):**
Mr. Lee faces a guarded short-term prognosis. The severe DAI carries a high risk of prolonged coma, vegetative state, or death. The presence of multiple traumatic injuries (femur fracture, rib fractures) increases the risk of secondary... | prognostic |
A 28-year-old African American male presents with a 6-month history of progressive vision loss in his left eye. He was initially diagnosed with uveitis by his primary care physician and treated with topical steroids with minimal improvement. He now reports significant glare, difficulty with night vision, and a central ... | Young age, but established systemic inflammatory disease.
Sarcoidosis ocular involvement often progressive, unpredictable.
Poorly controlled hypertension exacerbates retinal damage.
Central scotoma indicates macular involvement, poor prognosis.
OCT findings suggest irreversible retinal damage.
FA leakage indicates acti... | # Prognostic Assessment for Ocular Sarcoidosis
This 28-year-old African American male with ocular sarcoidosis presents a complex prognostic challenge due to multiple interacting factors. His case is considered high-risk due to the combination of active inflammation, macular involvement, poorly controlled hypertension,... | prognostic |
A 28-year-old female, previously healthy, presents with a 6-month history of progressively worsening dyspnea on exertion, non-productive cough, and fatigue. Initial workup revealed bilateral interstitial lung disease (ILD) pattern on CT scan. Lung biopsy confirmed a diagnosis of Idiopathic Pulmonary Fibrosis (IPF), usu... | IPF diagnosis confirmed, UIP pattern indicates aggressive disease.
Young age at onset suggests potentially faster progression.
Rapid decline in FVC and DLCO indicates poor prognosis.
Limited 6MWD signifies significant functional impairment.
Asthma comorbidity may complicate disease management.
Psychological distress hi... | # Prognostic Assessment for Idiopathic Pulmonary Fibrosis
This 28-year-old female with IPF presents a complex prognostic challenge due to several high-risk factors and interacting conditions. Her relatively young age at diagnosis, rapid disease progression despite pirfenidone, and significant functional impairment all... | prognostic |
Mr. Elias Vance is an 82-year-old African American male presenting for follow-up of Stage IIIB (T3N2M0) melanoma of the left lower leg, diagnosed 6 months ago. He underwent wide local excision and sentinel lymph node biopsy revealing 2/3 positive nodes. He completed adjuvant interferon-alpha therapy 3 months ago, but e... | Stage IIIB melanoma indicates high recurrence risk.
Positive lymph nodes worsen prognosis significantly.
Interferon discontinuation limits adjuvant benefit.
Acral lentiginous melanoma has poorer outcomes.
Diabetes and CKD increase complication risk.
Age 82 impacts treatment tolerance and recovery.
Social isolation hind... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case with multiple factors influencing his prognosis following Stage IIIB acral lentiginous melanoma. His prognosis requires careful consideration of disease-specific factors, comorbidities, functional status, and psychosocial elements.
**Short-... | prognostic |
A 16-year-old male, previously healthy, presents with a 6-month history of progressively worsening left thigh pain, initially attributed to sports injury. Recent imaging reveals a high-grade osteosarcoma of the left distal femur (biopsy confirmed). Staging workup (CT chest/abdomen/pelvis, bone scan) demonstrates multip... | High-grade osteosarcoma, metastatic disease present.
Multiple pulmonary nodules indicate advanced stage.
Large tumor size worsens prognosis significantly.
MDM2 amplification: aggressive tumor biology.
Elevated ALP/LDH: markers of disease burden.
ECOG 1: reduced functional status impacts treatment.
Asthma: potential che... | # Prognostic Assessment: Osteosarcoma with Pulmonary Metastases
This 16-year-old male with high-grade osteosarcoma and metastatic disease to the lungs presents a challenging prognostic scenario. Several factors contribute to a guarded prognosis.
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is foc... | prognostic |
Mr. David Lee is a 52-year-old African American male with a history of hypertension (diagnosed age 40, poorly controlled), type 2 diabetes mellitus (diagnosed age 45, managed with metformin and recently started on empagliflozin), hyperlipidemia (managed with atorvastatin), and a recent (3 months ago) non-ST elevation m... | Established CAD, recent NSTEMI, reduced ejection fraction.
Poorly controlled hypertension increases future risk.
Diabetes accelerates atherosclerosis, worsens outcomes.
Smoking history contributes to vascular damage.
Obesity exacerbates cardiac strain, insulin resistance.
Family history suggests genetic predisposition ... | # Prognostic Assessment for Mr. David Lee
**Short-Term Prognosis (Days to Weeks):**
Mr. Lee is at moderate risk for near-term adverse events, including recurrent ischemia, heart failure exacerbation, and stent thrombosis. His ongoing angina (CCS II) suggests incomplete revascularization or continued microvascular dysf... | prognostic |
A 28-year-old Hispanic female presents to the ED 72 hours after intentional ingestion of a large quantity of dapsone (estimated 12g) following a recent relationship breakup and job loss. She has a history of major depressive disorder, poorly controlled with intermittent SSRI use (fluoxetine, adherence variable). Initia... | Dapsone overdose: severe, multi-organ involvement present.
Renal failure complicates dapsone elimination significantly.
Hepatotoxicity adds to overall organ system burden.
Slow CYP2C19 metabolism: prolonged dapsone effects.
Depression & suicidal ideation: increased mortality risk.
Poor SSRI adherence: treatment resista... | # Prognostic Assessment: Dapsone Overdose
This 28-year-old female with a massive dapsone overdose presents a complex prognostic challenge due to multiple interacting factors. Her case is significantly complicated by acute renal failure, hepatotoxicity, underlying depression with suicidal ideation, and a genetic predis... | prognostic |
Mr. David Okoro, a 48-year-old Nigerian-American male, presents with a confirmed diagnosis of Systemic Lupus Erythematosus (SLE) complicated by lupus nephritis (Class IV-G, ISN/RPS classification) diagnosed 3 years ago. He initially responded to mycophenolate mofetil but experienced recurrent flares despite maintenance... | SLE nephritis Class IV-G indicates aggressive disease course.
Elevated creatinine, proteinuria signify kidney damage progression.
Low complement levels suggest active immunological process.
Diabetes, hypertension increase cardiovascular risk significantly.
Prior treatment failure indicates potential for refractoriness.... | # Prognostic Assessment for Mr. David Okoro
**Short-Term Prognosis (Days to Weeks):**
Mr. Okoro is at moderate risk for acute kidney injury and cardiovascular events in the immediate future. The recent increase in creatinine and persistent proteinuria, coupled with his underlying hypertension and diabetes, necessitate... | prognostic |
A 2.5-year-old male presents with a known diagnosis of Crohn's Disease, confirmed via endoscopy and histology 6 months prior. Initial presentation involved perianal fistulas and rectal bleeding. He has experienced frequent flares despite initial treatment with exclusive enteral nutrition (EEN). Current flare presents w... | Crohn’s: severe, early-onset, extensive disease involvement.
NOD2 variant: increases risk of complicated disease course.
Failure EEN: poor initial treatment response is concerning.
Failure steroids: suggests aggressive, refractory inflammation.
Low albumin: indicates significant nutritional compromise.
Elevated CRP/ESR... | # Prognostic Assessment: Crohn's Disease in a Toddler
This 2.5-year-old male with Crohn's Disease presents a high-risk scenario requiring careful prognostic assessment. His disease is characterized by early onset, extensive involvement, and a lack of response to first-line therapies, complicated by significant comorbi... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a 15-year history of severe, uncontrolled allergic asthma, complicated by chronic obstructive pulmonary disease (COPD) secondary to a 40-pack-year smoking history (quit 10 years ago). He was diagnosed with idiopathic pulmonary fibrosis (IPF) 3 years ago, confirmed by HR... | Asthma/COPD overlap significantly worsens respiratory function.
IPF progression is rapid, impacting long-term survival.
Frequent steroid use increases infection risk, morbidity.
Advanced age reduces physiological reserve, recovery potential.
Atrial fibrillation increases thromboembolic and cardiac risk.
Poor functional... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple interacting conditions significantly impacting his prognosis. His combination of severe allergic asthma, COPD, and rapidly progressive IPF creates a particularly challenging clinical scenario.
**Short-Term Prognosis... | prognostic |
Mr. David Miller is a 52-year-old male presenting for rheumatology follow-up. He was diagnosed with seropositive Rheumatoid Arthritis (RA) 8 years ago. Initially, he responded well to methotrexate, but experienced disease flares with increasing methotrexate doses. He was switched to a TNF inhibitor (etanercept) 5 years... | Established RA, long duration, poor response to multiple therapies.
Seropositivity (RF/CCP) indicates aggressive disease course.
Extra-articular manifestations worsen overall prognosis.
Sjögren’s syndrome increases risk of lymphoma and vasculitis.
Peripheral neuropathy suggests vascular or nerve involvement.
Smoking hi... | # Prognostic Assessment for Mr. David Miller
Mr. Miller presents a complex case of established, aggressive seropositive RA with significant comorbidities and extra-articular manifestations, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is likely to continue exper... | prognostic |
A 28-year-old African American female presents with a confirmed diagnosis of Takayasu Arteritis (TA) affecting the ascending aorta and left subclavian artery, diagnosed 6 months ago based on clinical presentation, imaging (MRI angiography demonstrating vessel wall thickening and stenosis), and inflammatory markers (ele... | Young age, female gender: generally better TA prognosis.
Large vessel involvement: indicates potentially aggressive disease.
Recent flare despite steroid use: treatment refractoriness.
Significant BP discrepancy: suggests aortic arch compromise.
Asthma complicates immunosuppression choices.
Family history of CAD: incre... | # Prognostic Assessment for Takayasu Arteritis
This 28-year-old female with Takayasu Arteritis presents a complex prognostic challenge due to a combination of disease characteristics, comorbidities, and psychosocial factors. The limited prognostic data available for TA necessitates a nuanced, individualized assessment... | prognostic |
A 16-year-old male presents with a 6-month history of progressively worsening vision in his left eye. He was initially diagnosed with retinitis pigmentosa (RP) based on visual field testing, fundus examination revealing bone spicule pigmentation, and electroretinogram (ERG) showing severely reduced rod and cone functio... | RP severity: homozygous *RHO* mutation indicates aggressive disease.
Age of onset: early onset predicts faster visual loss.
Visual acuity: left eye already significantly impaired.
ERG findings: severely reduced function, poor prognostic indicator.
OCT: outer retinal thinning confirms ongoing degeneration.
Asthma: corti... | # Prognostic Assessment for Retinitis Pigmentosa
This 16-year-old male with *RHO*-related RP presents a complex case with multiple factors influencing his prognosis. His homozygous *RHO* mutation, coupled with early onset and rapid progression evidenced by severely reduced ERG and OCT findings, indicates a particularl... | prognostic |
A 9-year-old female presents with recurrent urinary tract infections (UTIs) despite prophylactic antibiotics. Initial workup revealed bilateral vesicoureteral reflux (VUR), grade IV on the right and grade III on the left. She was diagnosed with Reflux Nephropathy (RN) at age 3. Recent renal ultrasound shows decreased r... | RN severity: Bilateral, high-grade VUR, declining renal function.
Age of diagnosis: Early RN onset predicts worse long-term outcomes.
GFR decline: Indicates progressive renal damage, poor prognosis.
UPCR elevation: Suggests glomerular involvement, disease progression.
Hypertension: Early hypertension accelerates RN pro... | # Prognostic Assessment for Reflux Nephropathy
This 9-year-old female with bilateral reflux nephropathy presents a complex case with multiple factors influencing her prognosis. Her early diagnosis, high-grade VUR, declining renal function, and emerging hypertension paint a concerning picture.
**Short-Term Prognosis (... | prognostic |
A 28-year-old African American male presents with a confirmed diagnosis of Stage IV Non-Small Cell Lung Cancer (NSCLC) with adenocarcinoma histology. He is a former smoker (1 pack/day for 8 years, quit 2 years ago). Genetic testing revealed an EGFR exon 21 L858R mutation. He also has a history of poorly controlled Type... | Stage IV NSCLC indicates inherently poor prognosis.
EGFR mutation suggests potential targeted therapy response.
Smoking history contributes to disease aggressiveness.
Comorbidities worsen overall health and treatment tolerance.
ECOG 1 suggests moderate functional impairment.
Limited social support impacts adherence and... | # Prognostic Assessment for Stage IV NSCLC
This 28-year-old African American male with Stage IV EGFR-mutated NSCLC faces a challenging prognosis, significantly impacted by multiple adverse factors.
**Short-Term Prognosis (Days to Weeks):** The immediate prognosis focuses on symptom control (pain, dyspnea) and initia... | prognostic |
Mrs. Evelyn Reed is a 72-year-old African American woman with a history of hypertension, type 2 diabetes mellitus (poorly controlled, HbA1c 9.2%), and stage II chronic kidney disease (eGFR 65 mL/min/1.73m²) presenting with newly diagnosed Stage IIIC (T3N2M0) serous papillary ovarian cancer. She was diagnosed after pres... | Advanced stage cancer significantly impacts short-term survival.
BRCA1 mutation suggests potential PARP inhibitor response.
Poor diabetes control worsens treatment tolerance, recovery.
Renal insufficiency limits platinum-based therapy options.
Neurotoxicity impacts functional status, quality of life.
Age increases risk... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):**
Mrs. Reed’s immediate prognosis is relatively stable following completion of chemotherapy. However, she remains at risk for chemotherapy-related complications, particularly worsening peripheral neuropathy and potential infections du... | prognostic |
A 72-year-old African American female with a history of hypertension, type 2 diabetes mellitus (managed with metformin), chronic kidney disease stage 3a (eGFR 48 mL/min/1.73m²), and prior stroke (left MCA, resulting in mild right-sided weakness) presents to the Emergency Department with acute decompensated heart failur... | Acute decompensated heart failure, significant symptom burden.
Advanced age increases risk of adverse outcomes.
Atrial fibrillation complicates management, stroke risk.
Chronic kidney disease worsens heart failure prognosis.
Prior stroke impacts functional status and recovery.
Diabetes exacerbates cardiovascular diseas... | # Prognostic Assessment for Acute Decompensated Heart Failure
This 72-year-old African American female with multiple comorbidities presents a complex prognostic challenge. Her acute decompensated heart failure is complicated by atrial fibrillation, chronic kidney disease, prior stroke, diabetes, and poor social suppor... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting with a non-pathologic hip fracture following a ground-level fall. He has a history of well-controlled type 2 diabetes mellitus (HbA1c 7.1%), chronic kidney disease stage 3a (eGFR 48 ml/min/1.73m2), and a prior history of ischemic stroke 5 years ago ... | Intertrochanteric fracture, generally better prognosis than other types.
Advanced age significantly increases complication risk post-surgery.
Diabetes impairs healing and elevates infection potential.
CKD 3a increases surgical and anesthetic risks substantially.
Prior stroke impacts rehabilitation potential and functio... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case with multiple comorbidities impacting his prognosis following a hip fracture. His advanced age, coupled with pre-existing conditions and social circumstances, necessitates a cautious and realistic assessment.
**Short-Term Prognosis (Day... | prognostic |
An 8-year-old male, previously healthy, presents with a 3-week history of progressively worsening neurological symptoms following confirmed *Streptococcus suis* meningitis acquired after close contact with pigs on a family farm. Initial presentation included fever, headache, and nuchal rigidity. Lumbar puncture reveale... | Confirm *S. suis* meningitis with neurological sequelae.
Assess infarct size and vasospasm severity.
Evaluate asthma control and potential exacerbations.
Consider psychosocial stress impacting recovery.
Determine pre-illness functional baseline.
Identify risk factors for poor neurological outcome.
Review limited *S. su... | # Prognostic Assessment for *Streptococcus suis* Meningitis with MCA Infarct
This 8-year-old boy presents a complex case of *Streptococcus suis* meningitis complicated by a large MCA infarct, posing significant prognostic challenges. The combination of infection, stroke, and psychosocial stressors necessitates a nuanc... | prognostic |
A 16-year-old African American female presents with a 6-month history of progressive weakness and sensory changes. Initial evaluation revealed a diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) with AQP4-IgG antibodies confirmed. She initially presented with bilateral optic neuritis, followed by longitudinal... | NMOSD severity: Relapsing, LETM, incomplete recovery.
AQP4-IgG positive: Indicates aggressive disease course.
Multiple relapses: Suggests treatment refractoriness.
TREM2 variant: Potentially faster progression risk.
Asthma: May limit steroid use, impacting treatment.
Family SLE history: Autoimmune predisposition concer... | # Prognostic Assessment for Neuromyelitis Optica Spectrum Disorder (NMOSD)
This 16-year-old female with AQP4-IgG positive NMOSD presents a complex prognostic challenge due to multiple high-risk factors. Her disease course has been aggressive, with two relapses despite steroid treatment, and the presence of a *TREM2* v... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a 15-year history of Type 2 Diabetes Mellitus, poorly controlled (HbA1c consistently >9.5%). He was diagnosed with Addison’s Disease 3 years ago, currently managed with hydrocortisone 20mg daily and fludrocortisone 0.1mg daily. He presents with worsening fatigue, uninten... | Addison’s disease severity: inadequate replacement, adrenal crisis risk.
Diabetes control: very poor, accelerating microvascular damage.
Renal function: declining, impacting medication metabolism/excretion.
Cardiovascular disease: pre-existing, increases mortality risk.
Functional status: declining, predicts poorer out... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple interacting conditions significantly impacting his prognosis. His Addison’s Disease, poorly controlled diabetes, chronic kidney disease, and cardiovascular disease create a high-risk scenario. His declining functiona... | prognostic |
A 72-year-old female, Mrs. Eleanor Vance, presents with Stage IV HER2-positive metastatic breast cancer. Her primary tumor was diagnosed 3 years ago as invasive ductal carcinoma, initially Stage IIB (T2N1M0). She underwent lumpectomy, sentinel lymph node biopsy (1 positive node), chemotherapy (doxorubicin/cyclophospham... | Stage IV HER2+ breast cancer indicates advanced disease.
Visceral crisis (lung nodule, pleural effusions) worsens prognosis.
Prior treatment failure suggests acquired resistance.
ECOG 2 indicates declining functional status.
Elevated LDH signifies aggressive disease biology.
Hypoalbuminemia reflects poor nutritional st... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):** Mrs. Vance is at risk of rapid deterioration due to progressive disease and associated complications. Her increasing bone pain, shortness of breath, and pleural effusions require immediate palliative care intervention. Symptom con... | prognostic |
Mrs. Elena Rodriguez is an 82-year-old Hispanic female presenting with worsening cognitive impairment and motor deficits. She was diagnosed with probable Alzheimer’s Disease (AD) with mixed vascular contributions 3 years ago, confirmed by amyloid PET scan and MRI showing both atrophy and white matter hyperintensities. ... | AD severity: Moderate, progressing with vascular component.
APOE ε4 allele: Increases risk of faster progression.
Vascular disease: Contributes to cognitive decline, poorer outcome.
Age 82: Higher risk of rapid functional deterioration.
Diabetes: Increases vascular risk, impacts cognitive reserve.
Stroke history: Prior... | # Prognostic Assessment for Mrs. Elena Rodriguez
Mrs. Rodriguez presents a complex case of probable Alzheimer’s Disease complicated by vascular contributions, comorbidities, and advanced age. Her prognosis requires careful consideration of multiple interacting factors.
**Short-Term Prognosis (Days to Weeks):**
Mrs. R... | prognostic |
Ethan, an 8-year-old male, presents with a known diagnosis of Crohn’s Disease, ileocolonic involvement, diagnosed 2 years ago. Initial presentation included abdominal pain, bloody diarrhea, and failure to thrive. He has experienced multiple flares despite escalating therapy. Current medications include azathioprine 2mg... | Ileocolonic Crohn’s: severe, extensive disease impacts prognosis.
Perianal fistulas: indicate aggressive, treatment-refractory disease.
Failure to thrive: malnutrition worsens outcomes significantly.
*NOD2* mutation: associated with earlier age of onset, severity.
Azathioprine failure: suggests limited response to immu... | # Prognostic Assessment for Ethan – Crohn’s Disease
**Short-Term Prognosis (Days to Weeks):**
Ethan is at high risk for continued flares requiring hospitalization. The active perianal disease and malnutrition contribute to significant discomfort and potential for infection. Expect continued need for corticosteroid bur... | prognostic |
A 28-year-old male presents with a known diagnosis of Stage IV Non-Small Cell Lung Cancer (NSCLC) with adenocarcinoma histology, harboring an EGFR exon 21 L858R mutation. He was initially diagnosed 6 months ago with a 7cm right upper lobe mass and widespread metastatic disease to the brain, liver, and bone. He initiall... | Adenocarcinoma, Stage IV: inherently poor prognosis.
EGFR mutation: initially responsive, now progressing.
Brain metastases: indicate aggressive disease course.
Osimertinib resistance: limits treatment options.
Smoking history: increases risk of second mutations.
Diabetes & CKD: complicate treatment, worsen outcomes.
E... | # Prognostic Assessment for Stage IV NSCLC
This 28-year-old male with Stage IV EGFR-mutated NSCLC presents a complex prognostic scenario due to multiple interacting factors. His initial response to Osimertinib was encouraging, but the development of progressive disease despite continued therapy signifies acquired resi... | prognostic |
A 7-day-old female infant, born at 30 weeks gestation (birth weight 1.2kg), presents with respiratory distress. She was diagnosed with Bronchopulmonary Dysplasia (BPD) – Stage 3 (severe) based on oxygen requirement >30% and radiographic findings. She also has a patent ductus arteriosus (PDA) – large, hemodynamically si... | Prematurity significantly increases BPD and PDA risk.
Severe BPD (Stage 3) indicates poorer respiratory outcomes.
Hemodynamically significant PDA worsens pulmonary hypertension.
Maternal hypertension links to infant cardiovascular issues.
Late-onset sepsis complicates recovery, increases morbidity.
Coagulase-negative S... | # Prognostic Assessment for a 7-Day-Old Female Infant with Severe BPD, PDA, and Sepsis
This infant presents a complex case with multiple interacting factors significantly impacting her prognosis. The combination of extreme prematurity, severe BPD, a large PDA, recurrent sepsis, and challenging psychosocial circumstanc... | prognostic |
Mr. David Miller is a 28-year-old male diagnosed 6 months ago with Stage III Hodgkin Lymphoma, Classical Hodgkin Lymphoma, nodular sclerosis subtype. Initial staging showed involvement of cervical, mediastinal, and axillary lymph nodes. He completed 6 cycles of ABVD chemotherapy (Adriamycin, Bleomycin, Vinblastine, Dac... | Stage III Hodgkin’s, refractory disease post-ABVD.
Persistent FDG avidity indicates treatment failure.
Elevated LDH suggests higher disease burden.
Smoking history increases secondary malignancy risk.
Depression impacts treatment adherence and quality of life.
ECOG 1: relatively good functional status currently.
Limite... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller faces a guarded short-term prognosis. The persistent disease after ABVD chemotherapy necessitates prompt salvage therapy. He is at risk for disease progression and associated symptoms (fatigue, night sweats, weight loss).... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of Stage III (T3N1M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He completed 6 cycles of cisplatin/pemetrexed chemotherapy, with partial response noted on imaging 3 months ago. He presents to the pre-operative clinic ... | NSCLC stage III, partial response, post-chemotherapy.
Severe COPD significantly increases perioperative risk.
Cardiac history (LVEF 45%) adds to anesthetic challenge.
Diabetes poorly controlled, impacting wound healing.
Low FEV1/DLCO: high risk of post-op respiratory failure.
ECOG 2: limited reserve, slower recovery ex... | # Prognostic Assessment for Mr. Arthur Penhaligon
This case presents a high-risk patient undergoing major thoracic surgery for NSCLC, complicated by significant comorbidities and functional limitations. Prognostic assessment must consider both short-term surgical risks and long-term oncologic outcomes.
**Short-Term P... | prognostic |
A 6-month-old male infant presents with a known diagnosis of Bilateral Renal Hypodysplasia (BRHD) detected prenatally via fetal ultrasound showing oligohydramnios and small kidneys. He was born at 36 weeks gestation, weighing 2.2kg (below 3rd percentile). Initial postnatal investigations confirmed bilateral small, echo... | Severe renal insufficiency present; GFR critically low.
Early age of onset indicates poor developmental potential.
Nutritional compromise exacerbates renal and overall health.
Recurrent infections worsen kidney damage and morbidity.
Chronic lung disease complicates respiratory management.
Hyperphosphatemia, hypocalcemi... | # Prognostic Assessment for Bilateral Renal Hypodysplasia (BRHD)
This 6-month-old infant with BRHD faces a very challenging prognosis. The combination of severe renal insufficiency, early onset, growth failure, chronic lung disease, and adverse social factors significantly impacts expected outcomes.
**Short-Term Prog... | prognostic |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.